495 Results
Guidelines and Advice
Status: Current
ID: Guideline Endorsement C50-CIDAP-3
ID: Guideline Endorsement C50-CIDAP-3
Mar 2025
Drug
Jul 2025
Document
May 2025
Document
May 2025
Document
May 2025
Document
May 2025
Document
May 2025
Document
Document
Document
May 2025
Document
May 2025
Document
May 2025
